News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Daily News Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk Todd Neale December 12, 2023
News Daily News Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets Michael O'Riordan September 14, 2023
News Daily News First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists L.A. McKeown August 31, 2023
News Features Chaos and Questions: New Public-Access Policies Put Journals in Flux Michael O'Riordan August 14, 2023
News Daily News Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs Michael O'Riordan July 11, 2023
News Conference News ADA 2023 Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide L.A. McKeown June 28, 2023
News Daily News Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes Michael O'Riordan June 23, 2023
News Daily News US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy Michael O'Riordan June 19, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Daily News Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show Caitlin E. Cox April 19, 2023
News Conference News ACC 2023 Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT Yael L. Maxwell March 07, 2023
News Daily News Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC Michael O'Riordan March 01, 2023
News Daily News In COVID-19 Patients, Vaccination Linked to Lower MACE Risk Michael O'Riordan February 22, 2023
News Daily News REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD L.A. McKeown January 24, 2023
News Daily News UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy Michael O'Riordan January 20, 2023
News Daily News RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads Todd Neale January 19, 2023